DUBLIN, May 10, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Immunohistochemistry (IHC) Market Analysis By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Drug Testing), By End-Use (Hospitals, Diagnostic Laboratories, Research Institutes), And Segment Forecasts, 2014 - 2025" report to their offering.
The global immunohistochemistry (IHC) market is estimated to reach a value of USD 3.1 billion by 2025
The rising prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are recognized to be the most influential factors driving the growth of the immunohistochemistry market. Furthermore, the rapid growth of biotech industry highlighted by increase in growth and revenue coupled with increase in stock market capitalization will nurture the growth.
Cancer has high morbidity and mortality risk associated with them. The diagnosis of the disease is majorly dependent on the stage of the disease at admission. This has led to the high demand of immunohistochemistry products. IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning the treatment for the disease, creating a demand for immunohistochemistry products. In addition, the rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and the increasing approvals of the same by the FDA to treat specific types of cancer are expected to benefit the growth in the long run.
Other important factors driving growth include the alarming rise in healthcare spending and the shift in focus on value-based healthcare solutions. In 2015, the U.S. healthcare spending witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the issue and establish a more value-based healthcare delivery, hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes.
Further key findings from the study suggest:
- North America registered the largest growth rate in the immunohistochemistry market in 2016
- The APAC region is expected to witness the fastest growth owing to increasing healthcare expenses driven by expanding aging population offering significant growth opportunities for players
- The hospitals and diagnostic laboratories segment accounted for the largest share of the immunohistochemistry market, by end-use due to the growing application of immunohistochemistry products for diagnostic procedures
- The antibody segment accounted for the largest share of immunohistochemistry market due to the increase in approvals by regulatory bodies for therapeutic antibody products
- Key players mapped in the report include Abcam plc, Agilent Technologies, BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck Millipore, PerkinElmer Inc., and Thermo Fisher Scientific Inc.
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. Immunohistochemistry Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Immunohistochemistry: Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.3.1. Key opportunities prioritized, by product
3.3.2. Key opportunities prioritized, by application
3.3.3. Key opportunities prioritized, by end-use
3.4. Immunohistochemistry - SWOT Analysis, By Factor (Political & legal, economic and technological)
4. Immunohistochemistry: Product Estimates & Trend Analysis
4.1. Immunohistochemistry Market: Product Movement Analysis
4.2.2. Primary Antibodies
4.2.3. Secondary Antibodies
4.3.2. Histological Stains
4.3.3. Blocking Sera and Reagents
4.3.4. Chromogenic Substrates
4.3.5. Fixation Reagents
4.3.7. Organic Solvents
4.3.8. Proteolytic Enzymes
4.4.2. Slide Staining Systems
4.4.3. Tissue Microarrays
4.4.4. Tissue Processing Systems
4.4.5. Slide Scanners
5. Immunohistochemistry: Application Estimates & Trend Analysis
5.1. Immunohistochemistry Market: Application Movement Analysis
5.2.3. Infectious Diseases
5.2.4. Cardiovascular diseases
5.2.5. Autoimmune Diseases
5.2.6. Diabetes Mellitus
5.2.7. Nephrological Diseases
5.3. Drug Testing
6. Immunohistochemistry: End-Use Estimates & Trend Analysis
6.1. Immunohistochemistry Market: Application Movement Analysis
6.2. Hospitals and Diagnostic Laboratories
6.3. Research Institutes
7. Immunohistochemistry: Regional Estimates & Trend Analysis, by Product, Application, and End-use
8. Competitive Landscape
- CMR Naviscan Corporation
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Merck Millipore
- PerkinElmer, Inc.
- Thermo Fisher Scientific Inc.
For more information about this report visit http://www.researchandmarkets.com/research/gkgmnp/immunohistochemist
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/31-billion-immunohistochemistry-ihc-market-analysis-and-forecast-segments-2014-2025-by-product-application--end-uses---research-and-markets-300455123.html
SOURCE Research and Markets